Back
Ligand Pharmaceuticals 10K Form
Buy
64
LGND
Ligand Pharmaceuticals
Last Price:
117.32
Seasonality Move:
10.42%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-11-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2023-05-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2022-11-08 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
| 2022-08-09 | 10Q | LGND/Ligand Pharmaceuticals Quarterly |
Receive LGND News And Ratings
See the #1 stock for the next 7 days that we like better than LGND
LGND Financial Statistics
Sales & Book Value
| Annual Sales: | $131.31M |
|---|---|
| Cash Flow: | $11.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $46.04 |
| Price / Book: | 2.62 |
Profitability
| EPS (TTM): | 2.51000 |
|---|---|
| Net Income (TTM): | $45.24M |
| Gross Margin: | $120.8M |
| Return on Equity: | 5.97% |
| Return on Assets: | 5.27% |
Ligand Pharmaceuticals Earnings Forecast
Key Ligand Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 30 years for LGND is 91.99%.
- The Selling, General & Administrative Expenses for LGND have been equal to 40.20% of Gross Profit Margin.
- The Research & Development expenses have been 18.69% of Revenue.
- The Interest Expense is 1.26% of Operating Income.
- The Net Earning history of LGND is 39.72% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 19 years.
Ligand Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LGND |
| CUSIP: | 53220K |
| Website: | ligand.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.49 |
| Quick Ratio: | 10.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 41.07 |
|---|---|
| Forward P/E Ratio: | 20.02 |
LGND Technical Analysis vs Fundamental Analysis
Buy
64
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy or a Sell?
-
Ligand Pharmaceuticals stock is rated a Buy
The current Ligand Pharmaceuticals [LGND] share price is $122.07. The Score for LGND is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.